Cargando…

P1254: BASELINE HLA-DR-RESTRICTED NEOANTIGEN BURDEN OF AML BLASTS IMPACTS ON HLA-DR GENE EXPRESSION AT RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANT

Detalles Bibliográficos
Autores principales:	Charrot, Sarah, Ball, Jennifer, Copley, Findlay, Aries, James, Mee, Matthew, Theocharidis, Symeon, Heward, James, Gribben, John, Davies, Jeff
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430901/ http://dx.doi.org/10.1097/01.HS9.0000971904.35419.69

Ejemplares similares

P1253: REDUCED EXPRESSION OF THE CHEMOKINES CXCL2, CXCL3 AND CXCL8 PROVIDES A POTENTIAL MECHANISM PROMOTING IMMUNE EVASION FACILITATING AML RELAPSE FOLLOWING ALLOGENEIC HSCT
por: Charrot, Sarah, et al.
Publicado: (2023)

HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules
por: Denzin, Lisa K., et al.
Publicado: (1996)

Association of HLA-DR1, HLA-DR13, and HLA-DR16 Polymorphisms with Systemic Lupus Erythematosus: A Meta-Analysis
por: Wang, Tingrui, et al.
Publicado: (2022)

Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation
por: Ballou, Cassandra, et al.
Publicado: (2023)

Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15
por: Enz, Lukas Simon, et al.
Publicado: (2019)

Association of HLA-DR3 and HLA-DR15 Polymorphisms with Risk of Systemic Lupus Erythematosus
por: Xue, Ke, et al.
Publicado: (2018)

T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP
Publicado: (1989)

T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules
Publicado: (1992)

HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants
Publicado: (1985)

Fibrillary Glomerulonephritis Is Associated With HLA-DR7 and HLA-B35 Antigens
por: Andeen, Nicole K., et al.
Publicado: (2020)

Allogeneic induction of the human T cell-instructed monocyte procoagulant response is rapid and is elicited by HLA-DR
Publicado: (1983)

Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapy
por: Plewa, Natalia, et al.
Publicado: (2023)

The HLA-DRα Chain Is Modified by Polyubiquitination
por: Lapaque, Nicolas, et al.
Publicado: (2009)

Effect of Selenium on HLA-DR Expression of Thyrocytes
por: Balázs, Csaba, et al.
Publicado: (2012)

HLA-DR Association in Papillary Thyroid Carcinoma
por: Amoli, Mahsa M., et al.
Publicado: (2010)

The curious case of HLA‐DR‐positive APL
por: Devi, Kanta, et al.
Publicado: (2020)

Reverse-SSO hybridization provides an accurate and simple HLA-DR typing--a comparative study with HLA-DR serologic typing.
por: Lee, K. W., et al.
Publicado: (1994)

Structural requirements for pairing of alpha and beta chains in HLA-DR and HLA-DP molecules
Publicado: (1990)

HLA-DM Captures Partially Empty HLA-DR Molecules for Catalyzed Peptide Removal
por: Anders, Anne-Kathrin, et al.
Publicado: (2010)

CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML
por: Satlsar, Esmaeil Shahabi, et al.
Publicado: (2020)

Molecular Analysis of Thymopentin Binding to HLA-DR Molecules
por: Liu, Zuojia, et al.
Publicado: (2007)

HLA-DR polymorphism affects the interaction with CD4
Publicado: (1995)

Expression of HLA-DR antigen in large bowel carcinoma.
por: Chang, E. S., et al.
Publicado: (1995)

HLA-DR expression, cytokines and bioactive lipids in sepsis
por: Das, Undurti
Publicado: (2014)

HLA-DR expression on monocytes is decreased in polytraumatized patients
por: Vester, Helen, et al.
Publicado: (2015)

The HLA-DR4 family of haplotypes consists of series of distinct DR and DS molecules
Publicado: (1984)

An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML
por: van der Lee, Dyantha I., et al.
Publicado: (2021)

Letter Regarding “Fibrillary Glomerulonephritis Is Associated With HLA-DR7 and HLA-B35 Antigens”
por: El Ters, Mireille, et al.
Publicado: (2020)

Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes
por: Castro, Andrea, et al.
Publicado: (2019)

Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition
por: Szeto, Christopher, et al.
Publicado: (2020)

Comment: In Response to “CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML”
por: Gajendra, Smeeta
Publicado: (2020)

Characterising the prognostic potential of HLA-DR during colorectal cancer development
por: Dunne, Margaret R., et al.
Publicado: (2020)

HLA-DR and HLA-DQ alleles in patients from the south of Brazil: markers for leprosy susceptibility and resistance
por: da Silva, Samira A, et al.
Publicado: (2009)

Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ
por: Hrdinová, Johana, et al.
Publicado: (2018)

Analysis of the Influence of HLA-A Matching Relative to HLA-B and -DR Matching on Heart Transplant Outcomes
por: Ansari, David, et al.
Publicado: (2015)

CIITA methylation and decreased levels of HLA-DR in tumour progression
por: Iizuka, N, et al.
Publicado: (2004)

Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease
Publicado: (1984)

Peptide binding predictions for HLA DR, DP and DQ molecules
por: Wang, Peng, et al.
Publicado: (2010)

HLA-DR expression on monocytes and the T-cell subset in septic patients
por: Menestrina, N, et al.
Publicado: (2005)

HLA-DR Antigen Expression on the Thyrocytes of Graves’ Disease Patients
por: Lee, Myung Shik, et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_j4c26vrh19su28hn35uqjh87kv